Credit Suisse Ag Atara Biotherapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$2.8 - $5.46 $23,758 - $46,328	8,485 Added 9.8%	95,056 $275,000
Q4 2022 Feb 13, 2023	BUY	$2.85 - $5.18 $71,395 - $129,764	25,051 Added 40.72%	86,571 $283,000
Q3 2022 Nov 10, 2022	BUY	$2.85 - $8.73 $3,095 - $9,480	1,086 Added 1.8%	61,520 $232,000
Q2 2022 Aug 12, 2022	SELL	$4.69 - $9.84 $20,420 - $42,843	-4,354 Reduced 6.72%	60,434 $471,000
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $39,549 - $79,146	4,686 Added 7.8%	64,788 $602,000

Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $11.8 Million - $15.9 Million	-800,637 Reduced 93.02%	60,102 $946,000
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $4.44 Million - $6.62 Million	-370,055 Reduced 30.07%	860,739 $15.4 Million
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $16.5 Million - $21.2 Million	-1,276,902 Reduced 50.92%	1,230,794 $19.1 Million
Q1 2021 May 14, 2021	BUY	$14.0 - $20.72 $16.5 Million - $24.4 Million	1,178,208 Added 88.62%	2,507,696 $36 Million
Q4 2020 Feb 12, 2021	SELL	$12.67 - $26.23 $419,389 - $868,239	-33,101 Reduced 2.43%	1,329,488 $26.1 Million
Q3 2020 Nov 13, 2020	SELL	$11.92 - $15.87 $2.55 Million - $3.39 Million	-213,897 Reduced 13.57%	1,362,589 $17.7 Million
Q2 2020 Aug 12, 2020	BUY	$7.53 - $14.93 $11.5 Million - $22.8 Million	1,528,876 Added 3211.25%	1,576,486 $23 Million
Q1 2020 May 13, 2020	SELL	$5.69 - $17.78 $62,299 - $194,673	-10,949 Reduced 18.7%	47,610 $405,000
Q4 2019 Feb 12, 2020	BUY	$10.89 - $16.79 $281,158 - $433,484	25,818 Added 78.86%	58,559 $964,000
Q3 2019 Nov 12, 2019	BUY	$12.03 - $19.94 $90,790 - $150,487	7,547 Added 29.96%	32,741 $462,000
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $9,810 - $21,135	-515 Reduced 2.0%	25,194 $507,000
Q1 2019 May 14, 2019	SELL	$28.4 - $41.74 $41,890 - $61,566	-1,475 Reduced 5.43%	25,709 $1.02 Million
Q4 2018 Feb 13, 2019	BUY	$30.9 - $42.97 $133,426 - $185,544	4,318 Added 18.88%	27,184 $944,000
Q3 2018 Nov 13, 2018	SELL	$35.05 - $43.5 $516,146 - $640,581	-14,726 Reduced 39.17%	22,866 $946,000
Q2 2018 Aug 14, 2018	SELL	$35.15 - $51.45 $114,905 - $168,190	-3,269 Reduced 8.0%	37,592 $1.38 Million
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $392,202 - $1.05 Million	21,789 Added 114.25%	40,861 $1.59 Million
Q4 2017 Feb 14, 2018	SELL	$13.2 - $18.1 $85,932 - $117,831	-6,510 Reduced 25.45%	19,072 $345,000
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $162,484 - $209,084	12,263 Added 92.07%	25,582 $423,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,319	13,319 $187,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account